Sign In
Buy JNJ
$241.00
+1.92 (+0.80%)
At Close: Jun 24, 2026
J&J (JNJ) Offers $8.9B Settlement for Talc Cancer Lawsuits
11:26am, Wednesday, 05'th Apr 2023
To completely resolve its cosmetic talc litigation, J&J (JNJ) offers a settlement amount of $8.9 billion payable over a period of 25 years.
U.S. private payroll rise by 145K, Johnson & Johnson's talc settlement, FedEx's cost-cutting plans
10:58am, Wednesday, 05'th Apr 2023
Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb Yahoo Finance Live's Brad Smith summarizes three key topics to watch for this morning. About Yahoo Finance: At Yahoo Finance, you get free stock quo
Johnson & Johnson shares rise after company proposes baby powder cancer settlement
10:47am, Wednesday, 05'th Apr 2023
Wall Street analysts were encouraged by J&J's proposal to pay $8.9 billion to settle claims that its baby powder and other talc products caused cancer.
Johnson & Johnson Pops After Sweetening Its Talc Settlement By Nearly $7 Billion
10:19am, Wednesday, 05'th Apr 2023
J&J reached a new $8.9 billion settlement in ongoing litigation over its talc-based baby powders, leading JNJ stock to rise Wednesday. The post Johnson & Johnson Pops After Sweetening Its Talc Settlem
Johnson & Johnson agrees to pay $8.9 billion to settle talc claims
10:05am, Wednesday, 05'th Apr 2023
#Johnson&Johnson Yahoo Finance's Anjalee Khemlani joins the Live show to break down Johnson & Johnson's $8.9 billion talc settlement.
JNJ Stock: The $8.9 Billion Reason Johnson & Johnson Is Up Today
09:24am, Wednesday, 05'th Apr 2023
Johnson & Johnson (NYSE: JNJ ) stock is climbing today. The conglomerate offered to pay $8.9 billion to resolve lawsuits related to the talc in its baby powder and other products.
Better Dividend Stock: AbbVie vs. Johnson & Johnson
08:55am, Wednesday, 05'th Apr 2023
Both healthcare giants are among the most elite dividend stocks on the market. AbbVie can handle the biosimilar challenges to Humira without it breaking the company.
J&J's on the Rise, but This Fintech Stock Is Falling Hard
08:52am, Wednesday, 05'th Apr 2023
Markets were poised for a quiet open on Wednesday morning. Johnson & Johnson upped its settlement offer regarding its liability for talc-related claims.
2 Dividend Kings That Are Likely to Raise Their Payouts This Month
08:00am, Wednesday, 05'th Apr 2023
J&J and P&G have been increasing their dividend payments for 60-plus years. Their payouts could go up by at least 5% if they are consistent with previous rate hikes.
J&J's talc litigation proposal is positive for stock and removes key overhang, say JPM analysts
07:04am, Wednesday, 05'th Apr 2023
Johnson & Johnson's JNJ, +1.05% decision to pay up to $8.9 billion over 25 years to settle claims connected with cosmetic-talc litigation is a positive for the stock as it removes the overhang of nega
Johnson & Johnson is again trying to use bankruptcy to settle talc cases for $8.9 billion
06:52pm, Tuesday, 04'th Apr 2023
Johnson & Johnson is trying once again to use the bankruptcy courts to settle tens of thousands of cases that claim its talc products cause cancer. The pharmaceutical company is now willing to pay $8.
J&J subsidiary proposes $8.9B settlement to resolve TALC claims
05:22pm, Tuesday, 04'th Apr 2023
CNBC's Meg Tirrell joins 'Closing Bell: Overtime' to report on J&J subsidiary proposing a higher settlement amount.
Johnson & Johnson to Settle Talc Claims for $8.9 Billion. The Stock Is Jumping.
04:44pm, Tuesday, 04'th Apr 2023
In a press release, the company said that its subsidiary, LTL Management, would refile for bankruptcy protection.
Johnson & Johnson Proposes Paying $9 Billion to Settle Talc Lawsuits
04:36pm, Tuesday, 04'th Apr 2023
A unit of the health-products company is also refiling for bankruptcy protection to seek approval for the settlement plan.
